Axsome Therapeutics, Inc. — Form D

Axsome Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-07. The offering totals $2.0M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2015-01-07
Form: D
Accession: 0001579428-15-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $2.0M
Amount sold: $1.3M
Remaining: $685K
Minimum investment: $25K
Investors: 4
Date of first sale: 2014-12-30
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-231594

Issuer

Name: Axsome Therapeutics, Inc.
CIK: 0001579428
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2012
Address: 45 ROCKEFELLER PLAZA, 20th Floor, NEW YORK, NY, 10111
Phone: 212-203-5072

Officers, directors & promoters (3)

Name	Role	Location
Herriot Tabuteau	Director	New York, NY
Herriot Tabuteau	Executive Officer	New York, NY
Herriot Tabuteau	Promoter	New York, NY

Other filings by this issuer (5)

Filed	Form	Offering	Sold
2015-05-19	D	$7.5M	$2.5M
2014-09-23	D	$7.5M	$2.0M
2013-10-30	D/A	$4.0M	$3.7M
2013-07-03	D	$3.5M	$1.2M
2013-06-19	D	$1.0M	$211K

More